$306.28
-2.09 (-0.678%)
At Close: Aug 04, 2026
Cencora Elects Lori J. Ryerkerk to Its Board of Directors
07:30am, Wednesday, 28'th May 2025
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that its Board of Directors has elected Lori J. Ryerkerk as a new independent director, effective June 1, 2025. “Ms. Rye
Cencora Continues To Deliver As A Healthcare Distributor With Further Growth Signs
08:37am, Friday, 16'th May 2025
Cencora gets a buy rating, agreeing with today's consensus from Wall St. The sector and macro environment points to continued demand for the healthcare supplies and niche specialty drugs Cencora can d
Here's Why Cencora (COR) is a Strong Momentum Stock
10:55am, Friday, 09'th May 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run?
10:16am, Thursday, 08'th May 2025
Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Cencora (COR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
06:00pm, Wednesday, 07'th May 2025
The headline numbers for Cencora (COR) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
COR Q2 Earnings & Revenues Beat Estimates, '25 EPS Guidance Raised
02:10pm, Wednesday, 07'th May 2025
COR's second-quarter fiscal 2025 results showcase a strong segmental performance. The company's earnings guidance for fiscal 2025 looks encouraging.
Cencora's Boosts Annual Forecast On Strong Demand For Weight Loss Drugs, Specialty Products Despite Mixed Q2 Earnings
02:06pm, Wednesday, 07'th May 2025
Cencora, Inc COR on Wednesday reported second-quarter 2025 sales increased 10.3% to $75.5 billion, missing the consensus of $75.68 billion, primarily due to an 11.4% increase in revenue within the U
Cencora, Inc. (COR) Q2 2025 Earnings Call Transcript
10:55am, Wednesday, 07'th May 2025
Cencora, Inc. (NYSE:COR ) Q2 2025 Earnings Conference Call May 7, 2025 8:30 AM ET Company Participants Bennett Murphy - Senior Vice President, Head of Investor Relations & Treasury Bob Mauch - Preside
Cencora (COR) Beats Q2 Earnings and Revenue Estimates
08:40am, Wednesday, 07'th May 2025
Cencora (COR) came out with quarterly earnings of $4.42 per share, beating the Zacks Consensus Estimate of $4.08 per share. This compares to earnings of $3.80 per share a year ago.
Cencora raises annual profit forecast on strong demand for specialty drugs
07:27am, Wednesday, 07'th May 2025
U.S. drug distributor Cencora raised its annual profit forecast on Wednesday, driven by robust demand for costly specialty medicines and weight-loss drugs.
Cencora Reports Fiscal 2025 Second Quarter Results
06:30am, Wednesday, 07'th May 2025
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 second quarter ended March 31, 2025, revenue increased 10.3 percent year-over-year to $75.5 billion.
MedTech Stocks' Earnings to Watch on May 7: COR, QDEL & INGN
11:15am, Tuesday, 06'th May 2025
The medical device sector saw steady sales growth in the first quarter of 2025, supported by innovation in AI, wearables, and personalized care. However, earnings gains were more modest as global tari
Camino Announces Exploration Results at Los Chapitos and Further Exploration Plans in Peru
06:00am, Tuesday, 06'th May 2025
VANCOUVER, BC / ACCESS Newswire / May 6, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) (WKN: A116E1) ("Camino" or the "Company") is pleased to announce exploration results at its Coppe
Will Speciality and GLP-1 Drugs Help COR Beat Q2 Earnings Estimates?
08:25am, Monday, 05'th May 2025
COR's fiscal second-quarter results are likely to reflect decent U.S. Healthcare Solutions segmental performance.
Unveiling Cencora (COR) Q2 Outlook: Wall Street Estimates for Key Metrics
10:20am, Friday, 02'nd May 2025
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Cencora (COR), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the qua
Sign In
Buy COR